Sector movers: Big pharma, support services pace gains
7th Sep 2020 14:57
(Sharecast News) - Big Pharma paced gains in London at the start of the week, led by shares in Dechra Pharmaceuticals after the veterinary drugs maker hiked its dividend payout following what it described as an "encouraging" start to its new financial year.
Read moreRussian vaccine candidate obtains positive peer reviews
4th Sep 2020 15:17
(Sharecast News) - Russia's Covid-19 vaccine candidate generated an immune response without any adverse side effects, according to a peer-reviewed study.
Read moreWHO does not expect mass Covid-19 vaccinations before mid-2021
4th Sep 2020 12:28
(Sharecast News) - The World Health Organization said on Friday it does not expect widespread vaccinations for Covid-19 until at least mid-2021.
Read moreUS CDC tells states to be ready to large-scale vaccination by 1 November
3rd Sep 2020 12:37
(Sharecast News) - America's Centers for Disease Control and Prevention in Atlanta has told state governments to make preparations for the large-scale distribution of a Covid-19 vaccine.
Read moreDHL warns of delivery issues for Covid-19n vaccine in poorer countries
3rd Sep 2020 10:25
(Sharecast News) - DHL warned on Thursday that two-thirds of the world's population is unlikely to have easy access to any Covid-19 vaccine requiring storage at freezing temperatures.
Read moreUS will not participate in international initiative to develop Covid-19 vaccine
2nd Sep 2020 09:12
(Sharecast News) - The US government said overnight that it will not participate in a global initiative to develop, manufacture and equitably distribute a vaccine for Covid-19 due to the World Health Organization's involvement.
Read moreAstraZeneca gets new Imfinzi approval, posts positive Farxiga results
1st Sep 2020 07:28
(Sharecast News) - AstraZeneca announced on Tuesday that 'Imfinzi', or durvalumab, has been approved in the European Union for the first-line treatment of adults with extensive-stage small cell lung cancer, in combination with a choice of chemotherapies, etoposide plus either carboplatin or cisplatin.
Read moreModerna says Covid-19 vaccine also generates antibodies among elderly
26th Aug 2020 16:56
(Sharecast News) - Moderna shares found a bid in the middle of the week after the biotechnology outfit announced that its experimental Covid-19 vaccine did generate antibodies against the disease in elderly patients.
Read moreOxford Covid-19 vaccine could be put before regulators this year
25th Aug 2020 08:22
(Sharecast News) - An experimental Covid-10 vaccine being developed by the University of Oxford and AstraZeneca could be put before regulators in 2020, the director of the Oxford Vaccine Group said on Tuesday.
Read moreFauci warns against premature EUA for Covid-19 vaccines
25th Aug 2020 07:51
(Sharecast News) - America's top health official warned of the risks of applying political pressure on the Food and Drug Administration to extend emergency use authorisation for its Covid-9 vaccine candidate before the November presidential elections in the US.
Read moreAstraZeneca starts trial of Covid-19 antibody treatment
25th Aug 2020 07:01
(Sharecast News) - AstraZeneca said the UK first participants have been dosed in a Phase I trial of a combination of two monoclonal antibodies (mAbs) to prevent and treat Covid-19.
Read moreSector movers: M&A speculation still in the driver's seat, Big Pharma gains
24th Aug 2020 15:23
(Sharecast News) - Mergers and acquisitions speculation continued to drive sector moves at the start of the week - yet again.
Read moreEurope open: 'Mini' trade deal, US Covid-19 treatment boost stocks
24th Aug 2020 12:13
(Sharecast News) - Stocks began the week with solid gains as investors cheered news that US health regulators had cleared the use of a potentially key treatment for Covid-19, convalescent plasma.
Read moreAstraZeneca rallies as Trump said to consider fast-tracking Covid vaccine
24th Aug 2020 11:46
(Sharecast News) - AstraZeneca shares rallied on Monday after it emerged that US President Donald Trump is considering fast-tracking an experimental Covid-19 vaccine being developed by the pharmaceuticals giant and Oxford University.
Read moreGoldman Sachs thinks markets underpricing odds for Covid-19 vaccine before year end
6th Aug 2020 15:23
(Sharecast News) - Goldman Sachs thinks the world will be in a very different place in three months' time on at least three front, so much so that investors' expectations for the outcomes will likely set the tone for trading until then.
Read more